NEOG
Neogen Corporation
Healthcare · Medical Devices · NMS
$8.90
Data: 2026-05-28
✓ ETHICAL PASS

Unknown MOAT
HIGH
Data Confidence: 85.7%
Key Metrics

How this company measures up on the fundamentals that matter

Market Cap
$2.0B
Total market value of the company
31.01
Based on estimated future earnings — lower means cheaper
Rev Growth
-4.4%
Year-over-year revenue change
Profit Margin
-69.9%
How much profit the company keeps from each dollar of revenue
-25.6%
Return on equity — how efficiently it uses shareholder money
Analyst Target
$12.00
+35% from current price — median analyst estimate
Recommendation
NONE
Consensus view from 3 analysts covering this stock
About Neogen Corporation

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides software systems that help testers analyze and store results; natural toxin tests; rapid sanitation tests; culture and prepared media products; filter tests for microbial analysis of water; sample collection products; and food safety analysis laboratory services. This segment sells its products to the milling and grain, meat and poultry, ready-to-eat, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. Its Animal Safety segment provides reagents and test kits for use in immunoassay production, forensic and animal toxicology, and life science research, as well as colorimetric and chemiluminescent substrates; veterinary instruments and disposables; animal care and other products, including digestive aids and nutritional supplements; rodent and insect control products, and disinfectants; and genomics services, such as DNA genotyping, sequencing, and trait analysis for livestock and companion animals. This segment sells its products to companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

https://www.neogen.com

Country: United States Employees: 2,974 Industry: Medical Devices
Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
0.0% N/A
Debt must be below 33% of total assets
Cash Ratio
0.0% N/A
Interest-bearing cash below 33% of assets
Receivables
0.0% N/A
Receivables below 49% of assets
Revenue Purity
0.0% PASS
Non-compliant revenue below 5% — any excess requires purification
Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

MARKDOWN
Price trending down — defensive positioning
0.020
Positive but modest risk-adjusted returns
-0.0142
No positive edge detected — the data suggests staying out
-0.214
Drawdown risk outweighs the returns — higher risk profile
Annual Return
-16.1%
Historical annualised return based on price data
-75.2%
Largest peak-to-trough decline — the worst it has been
BEAR
Statistical model detects bearish conditions
Days in State
76
How long the current regime has persisted — longer means more stable
Market Data

Trading characteristics and market positioning

1.84
Significantly more volatile than the market
52W High
$11.43
22% below the year high
52W Low
$4.53
96% above the year low
Avg Volume
2,678,003
Average daily shares traded — higher means easier to buy and sell
5.1
Days it would take all short sellers to cover — higher means more crowded
Short % Float
6.6%
Moderate short interest
N/A
Annual dividend as a percentage of the share price
$-2.80
Earnings per share over the last 12 months
Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

37.82
Heavy leverage — higher financial risk if revenues decline
3.92
Strong balance sheet — comfortably covers short-term obligations
Quick Ratio
1.97
Like current ratio but excludes inventory — stricter test
Gross Margin
45.2%
Revenue left after cost of goods — higher means pricing power
Operating Margin
-1.6%
Profit from core operations before interest and tax
$19M
Positive — the business generates more cash than it spends
Revenue (TTM)
$871M
Total revenue over the last 12 months
Net Income
$-608,844,032
Loss-making — spending exceeds revenue after all costs
Analyst Coverage
Analysts
3
Target High
$13.00
Target Median
$12.00
Target Low
$11.00
Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry (292 articles) Indicators Join Free →

Get our weekly market brief free.